Safety signaling is a key scientific disipline that often gets overlooked in personal injury case involving pharmacetutical or medical device products. John Clark and I recently published an article on this topic in the Defense Research Institute’s (DRI’s) quarterly publication, Rx For the Defense.
Safety signaling is a key scientific disipline that often gets overlooked in personal injury case involving pharmacetutical or medical device products. John Clark and I recently published an article on this topic in the Defense Research Institute’s (DRI’s) quarterly publication, Rx For the Defense.
In this piece, we address two important questions related to adverse event reporting: (1) whether or not the manufacturer had a duty to warn; and (2) if so, what was the time point at which a safety issue could/should have become known by the Company.
On Wednesday July 8, 2020, Dr. David Schwartz of Innovative Science Solutions presented at the IADC 2020 Virtual Annual Meeting on a panel titled The Use of Genetic Testing in the Courtroom. A complimentary copy of the panel presentation is now available for download. Read more
Dr. David Schwartz of Innovative Science Solutions will be presenting at the IADC 2020 Virtual Annual Meeting on a panel titled The Use of Genetic Testing in the Courtroom. Read more
Genetic Evidence Concerning Causation for Mesothelioma 16 June 2020 at 2pm Eastern Daylight Time. Read more
Plaintiff experts having been asserting for decades that all mesotheliomas must be linked to some asbestos exposure. Indeed, this has led to the erroneous (but widespread) view that mesothelioma is a signature disease, only caused by asbestos exposure. Read more
The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us today
Contact us